US 10092637
Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
granted A61KA61K2039/5258A61K2039/53
Quick answer
US patent 10092637 (Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/5258, A61K2039/53, A61K2039/57, A61K2039/575